Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"

Vista senzilla d'ítem
dc.contributor.authorMercader García, Pedro
dc.contributor.authorPastor-Nieto, María
dc.contributor.authorGonzález-Pérez, Ricardo
dc.contributor.authorGiménez Arnau, Anna Maria
dc.contributor.authorRuiz-Gonzalez, Inmaculada
dc.contributor.authorMora-Fernández, Verónica
dc.contributor.authorMiquel, Javier
dc.contributor.authorSilvestre Salvador, Juan Francisco
dc.contributor.authorSanz-Sánchez, Tatiana
dc.contributor.authorPerez-Feal, Patricia
dc.contributor.authorSánchez-Pérez, Javier
dc.contributor.authorHeras-Mendaza, Felipe
dc.contributor.authorSerra-Baldrich, Esther
dc.contributor.authorHervella Garcés, Marcos
dc.contributor.authorGatica-Ortega, María-Elena
dc.contributor.authorGarcía-Doval, Ignacio
dc.contributor.authorBorrego, Leopoldo
dc.date.accessioned2022-01-18T06:52:35Z
dc.date.issued2021
dc.format.mimetypeapplication/pdf
dc.identifier.citationMercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Borrego L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". Contact Dermatitis. 2021;85(5):611-3. DOI: 10.1111/cod.13941
dc.identifier.doihttp://dx.doi.org/10.1111/cod.13941
dc.identifier.issn0105-1873
dc.identifier.urihttp://hdl.handle.net/10230/52245
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofContact Dermatitis. 2021;85(5):611-3
dc.rightsThis is the peer reviewed version of the following article: Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Sanz-Sanchez T, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Borrego L. Arguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation". Contact Dermatitis. 2021;85(5):611-3. DOI: 10.1111/cod.13941, which has been published in final form at http://dx.doi.org/10.1111/cod.13941. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.keywordAllergic contact dermatitis
dc.subject.keywordEpidemiology
dc.subject.keywordMethyldibromo glutaronitrile
dc.titleArguments in favour of excluding MDBGN from the European baseline series. In response to "Comment on MDBGN/DBDCB, the European baseline series, and EU legislation"
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
Mercader_cd_argu.pdf
Mida:
146.56 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions